Nuffoods Spectrum India

BASF, Glycosyn to improve gut health with HMO

22 May 2019 | News

BASF and Glycosyn sign strategic partnership

image credit-

image credit-

German company BASF and US based firm Glycosyn have  signed a partnership agreement for the development and commercialization of human milk oligosaccharides (HMOs) for broad use in dietary supplements, functional nutrition, and medical food.

The strategic partnership includes exclusive license of Glycosyn´s patent portfolio for gut health beyond infant nutrition to BASF. The agreement aims to improve gastrointestinal health in adolescents and adults, along with broadening the applications of HMO for further health conditions.

As part of the collaboration and under the exclusive license, BASF will extend its offering of the most abundant HMO, 2’-Fucosyllactose (2’-FL) branded PREBILACTM, to a broad range of customers worldwide.  Glycosyn will leverage its scientific expertise and extensive collaboration with the HMO research community to expand the evidence for adult health.


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

© Copyright 2020. Nuffoods Spectrum. All Rights Reserved.
Web Interface Conceived and Powered By : SCI Knowledge Interlinks